資訊|論壇|病例

搜索

首頁(yè) 醫(yī)學(xué)論壇 專業(yè)文章 醫(yī)學(xué)進(jìn)展 簽約作者 病例中心 快問(wèn)診所 愛(ài)醫(yī)培訓(xùn) 醫(yī)學(xué)考試 在線題庫(kù) 醫(yī)學(xué)會(huì)議

您所在的位置:首頁(yè) > 腫瘤科診療指南 > 2011BCSH成熟T細(xì)胞和NK細(xì)胞癌診治指南

2011BCSH成熟T細(xì)胞和NK細(xì)胞癌診治指南

2014-04-29 20:41 閱讀:1300 來(lái)源:愛(ài)愛(ài)醫(yī) 責(zé)任編輯:張子玲
[導(dǎo)讀] The mature or pe**heral T-cell neoplasms are a biologically and clinicallyheterogeneous group of rare disorders that result from clonal proliferation ofmature post-thymic lymphocytes.

    《2011BCSH成熟T細(xì)胞和NK細(xì)胞癌診治指南》內(nèi)容簡(jiǎn)介:

    The mature or pe**heral T-cell neoplasms are a biologically and clinicallyheterogeneous group of rare disorders that result from clonal proliferation ofmature post-thymic lymphocytes.

    《2011BCSH成熟T細(xì)胞和NK細(xì)胞癌診治指南》內(nèi)容預(yù)覽:

    Natural killer(NK)cells are closely related to Tcells and neoplasms derived from these are therefore considered within thesame group. The World Health Organisation (WHO)classification ofhaemopoietic malignancies has divided this group of disorders into those withpredominantly leukaemic (disseminated), nodal, extra-nodal or cutaneouspresentation (Harris et al, 1999, Swerdlow et al, 2008) (Table 1)。 Within the WHOclassification these malignancies are differentiated on the basis not only ofclinical features but also of morphology, immunophenotype and genetics.

    點(diǎn)擊下載***:《2011BCSH成熟T細(xì)胞和NK細(xì)胞癌診治指南》


分享到:
  版權(quán)聲明:

  本站所注明來(lái)源為"愛(ài)愛(ài)醫(yī)"的文章,版權(quán)歸作者與本站共同所有,非經(jīng)授權(quán)不得轉(zhuǎn)載。

  本站所有轉(zhuǎn)載文章系出于傳遞更多信息之目的,且明確注明來(lái)源和作者,不希望被轉(zhuǎn)載的媒體或個(gè)人可與我們

  聯(lián)系z(mì)lzs@120.net,我們將立即進(jìn)行刪除處理

意見(jiàn)反饋 關(guān)于我們 隱私保護(hù) 版權(quán)聲明 友情鏈接 聯(lián)系我們

Copyright 2002-2024 Iiyi.Com All Rights Reserved